Pipeline
Licensing & BD
Clinical Trials
Careers
About Us
Back
Home
Resources
TrialSpark is rebranding to Formation Bio, effective December 5, 2023. Click here to learn more.
Glossary
A
Adherence
Adverse Event
C
Clinical Research Coordinator (CRC)
Clinical Study Design
Clinical Study Design Types
Clinical Trial
Concomitant Treatment or Medication
Control Group
D
Dosage
Double Blind
E
Efficacy
Eligibility Criteria
Enrollment
Exclusion Criteria
Extension Arm
F
FDA
H
HIPAA
I
Inclusion Criteria
Informed Consent
Institutional Review Board (IRB)
Investigational Product (IP)
O
Open Label Extension Study
P
Participant
Patient Reported Outcome (PRO)
Phases of a Trial
Placebo
Principal Investigator (PI)
Protocol
R
Randomization
Risks
S
Screening Period
Screening Visit
Serious Adverse Event
Side Effects
Single Blind
Sponsor
Standard of Care
Study Withdrawal
T
Titration
Treatment Group or Treatment Arm
Treatment or Drug
W
Wash-out Period
Close